Neose Technologies Reviews

0 Reviews
Recommend to a friend
Approve of CEO
(no image)
George J. Vergis
0 Ratings

Neose Technologies Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Horsham, PA
Size 16 to 50 Employees
Founded Unknown
Type Company - Public
Industry Unknown
Revenue $5 to $10 million (USD) per year
Competitors Amgen, Chugai, Sanofi-Aventis

Neose Technologies believes in the power of protein to treat disease. The company's lead protein drug candidates in clinical trials treat neutropenia (an abnormal decrease in a type of white blood cells) caused by chemotherapy and bleeding during surgery. Its products use enzymes to alter carbohydrate structures in certain kinds of proteins. The company formed partnerships with BioGeneriX and Novo Nordisk for the development and marketing of these drugs. Novo Nordisk is also helping Neose research future protein drug candidates for the treatment of different types of... More

Work at Neose Technologies? Share Your Experiences

Neose Technologies

Click to Rate